Studies have shown lower screening for sexually transmitted infections (STIs) during the COVID-19 pandemic. It is unclear how the pandemic affected STI testing among juvenile justice-involved youth, especially for extragenital gonorrhea and chlamydia. Retrospective chart review was conducted between March 2020 and June 2021 utilizing electronic health records of youth seen at a preadjudication facility in the southwest United States. Rates of extragenital testing were compared with prepandemic rates. Overall, 574 youth were observed; 86% were male, mean age was 15.4 years, and 48.6% were Black. Of the youth reporting performing oral sex, 57% were tested for oropharyngeal STIs compared to 33.5% in 2018 to 2019. Twenty percent of those reporting anal receptive sex were tested for rectal infections compared to 25.9% before the pandemic. Pandemic testing for oropharyngeal STIs increased but rectal testing decreased. Overall, testing rates remained low.
ChanP. A., RobinetteA., MontgomeryM., AlmonteA., Cu-UvinS., LonksJ. R., ChapinK. C., KojicE. M., & HardyE. J. (2016). Extragenital infections caused by Chlamydia trachomatis and Neisseria gonorrhoeae: A review of the literature. Infectious Diseases in Obstetrics and Gynecology, Article ID 5758387. https://doi.org/10.1155/2016/5758387
3.
CullinenK., HillM., AndersonT., JonesV., NelsonJ., HalawaniM., & ZhaP. (2021). Improving sexually transmitted infection screening, testing, and treatement among people with HIC: A mixed method needs assessment to inform a multi-site, multi-level intervention and education plan. PLoS One, 16(12), Article e0261824. https://doi.org/10.1371/journal.pone.0261824
4.
Dukers-MuijrersN. H. T. M., SchachterJ., van LiereG. A. F. S., WolffsP. F. G., & HoebeC. J. P. A. (2015). What is needed to guide testing for anorectal and pharyngeal Chlamydia trachomatis and Neisseria gonorrheae in women and men? Evidence and opinion. BMC Infectious Diseases, 15, 533. https://doi.org/10.1186/s12879-015-1280-6
5.
KentC. K., ChawJ. K., WongW., LiskaS., GibsonS., HubbardG., & KlausnerJ.D. (2005). Prevalence of rectal, urethral, and pharyngeal chlamydia and gonorrhea detected in 2 clinical settings among mem who have sex with men: San Francisco, California, 2003. Clinical Infectious Diseases, 41(1), 67–74. https://doi.org/10.1086/430704
6.
KooninL. M., HootsB., TsangC. A., LeroyZ., FarrisK., JollyB., AntallP., McCabeB., ZelisC. B. R., TongI., & HarrisA. M. (2020). Trends in the use of telehealth during the emergence of the COVID-19 pandemic—United States, January-March. (2020). Morbidity and Mortality Weekly Report, 69(43), 1595–1599. https://doi.org/10.15585/mmwr.mm6943a3
7.
MiddlebrookH., & RuudM. (2020). Extragenital screening for chlamydia and gonorrhea among adolescents and young adults at a sexual health clinic. Nursing for Women's Health, 24(4), 267–276. https://doi.org/10.1016/j.nwh.2020.05.007
8.
MulamreddyT., HollowayA., BeydaR., OshinE., & BenjaminsL. (2020). Prevalence of extragenital gonorrhea and chlamydia among youth involved in the juvenile justice system. Journal of Adolescent Health, 66(2),S2–S3. https://doi.org/10.1016/j.jadohealth.2019.11.007
9.
OgaleY., YehP. T., KennedyC. E., ToskinI., & NarasimhanM. (2019). Self-collection of samples as an additional approach to deliver testing services for sexually transmitted infections: A systematic review and meta-analysis. BMJ Global Health, 4(2), Article e001349. https://doi.org/10.1136/bmjgh-2018-001349
10.
PintoC. N., NilesJ. K., KaufmanH. W., MarloweE. M., AlagiaD. P., ChiG., & Van Der PolB. (2021). Impact of the COVID-19 pandemic on chlamydia and gonorrhea screening in the U.S. American Journal of Preventive Medicine, 61(3), 386–393. https://doi.org/10.1016/j.amepre.2021.03.009
11.
RobertsonA. A., ThomasC. B., St. LawrenceJ. S., & PackR. (2005). Predictors of infection with chlamydia or gonorrhea in incarcerated adolescents. Sexually Transmitted Infections, 32(2), 115–122. https://doi.org/10.1097/01.olq.0000151419
12.
RubinR. (2020). COVID-19's crushing effects on medical practices, some of which might not survive. JAMA, 324(4), 321–323. https://doi.org/10.1001/jama.2020.11254
13.
SpauldingA. C., RabeeahZ., González-MontalvoM. D. M, AkiyamaM. J., BakerB. J., BauerH. M., GibsonB. R., NijhawanA. E., ParvezF., WanguZ., ChanP. A., & Rollins Investigational Team on STIs inCorrections. (2022). Prevalence and management of sexually transmitted infections in correctional settings: A systematic review. Clinical Infectious Diseases, 74(Suppl. 2), S193–S217. https://doi.org/10.1093/cid/ciac122
14.
Tolou-ShamsM., HarrisonA., HirschtrittM., DauriaE., & Barr-WalkerJ. (2019). Substance use and HIV among justice-involved youth: Intersecting risks. Current HIV/AIDs Report, 16(1), 37–47. https://doi.org/10.1007/s11904-019-00424-x
15.
TrebachJ. D., ChaulkC. P., PageK. R., TuddenhamS., & GhanemK. G. (2015). Neisseria gonorrhoeae and Chlamydia trachomatis among women reporting extragenital exposure. Sexually Transmitted Diseases, 42(5), 233–239. https://doi.org/10.1097/OLQ.0000000000000248
16.
UpretyP., & CardenasA. M. (2019). Extragenital screening is essential for comprehensive detection of Chlamydia trachomatis and Neisseria gonorrhoeae in the pediatric population. Journal of Clinical Microbiology, 57(6), e00335-19. https://doi.org/10.1128/JCM.00335-19
